SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Robert K. who wrote (14145)7/19/2000 12:59:39 AM
From: Bluegreen  Respond to of 17367
 
Bob, some day...............real world real people. This is what I am talking about. Remember, speaking in general, clinicians have no common sense about preventive medicine and cost savings.....that is what spawned HMOs. Things might be changing. Now if there was a safe product to work in synergy with antibiotics. Think of money saved IF you can kill bugs RAPIDLY AND EFFECTIVELY.....NOTICE WORDING "START EARLY" IT'S THE PREVENTION.......It is the cost savings down the line IN MORE WAYS THAN ONE. DO you have any idea the cost per day in ICU???? Any idea of savings in suffering and damage to patients that have to endure prolonged high doses of Genta and Vanco??? Imagine an alternative where a patient might not have to languish in ICU for days or weeks hooked up to Vanco or Genta SLOWLY fighting off gram neg bugs. Think of the elderly, surgically compromised or immune compromised patients. Could there be some product that is safe that could be added to Genta or Vanco??? Now let's talk BARRIERS AND BACTERIAL INFECTIONS!!!!!>>>>>>>>>>>>>>: Surg Clin North Am 2000 Jun;80(3):895-909, ix-x Books
Contemporary issues with bacterial infection in the intensive care unit.
Reed RL 2nd
Department of Surgery, Loyola University Medical Center, Maywood, Illinois, USA.
Nosocomial infection in the critically ill results from defects in the intrinsic barriers to microbial invasion. The diagnosis is complicated by an inability to perform an adequate physical examination in a patient with several compounding findings, usually necessitating sophisticated technologies to aid in the diagnosis. Pneumonia, line sepsis, urosepsis, sinusitis, endocarditis, peritonitis, and acalculous cholecystitis are the more common infections that challenge the care of the critically ill. Antibiotic therapy is adjunctive to efforts to preserve the barrier, but should be started early, should be targeted as specifically as possible to the offending organisms, and should be dosed adequately to ensure an effective concentration in the infected tissue.<<<<<<<<<<<<